GENE ONLINE|News &
Opinion
Blog

.

Зеркало официального сайта всегда доступно для входа на Мостбет, даже при ограничениях. Скачать Mostbet – это шаг к удобству и азартным развлечениям.

Если вы ищете место для увлекательных ставок, обратите внимание на Joycasino, где лучшие предложения для игроков ждут вас.
last added cars
2021-09-30| M&A

Merck Acquires Acceleron for $11.5 Billion, Gaining Access to a Phase 3 Cardiovascular Asset

by Rajaneesh K. Gopinath
Share To
New Jersey-based Merck announced its plan to acquire Acceleron for $11.5 billion ($180 per share) in an all-cash deal that amounts to a whopping 38.5% premium of Acceleron's stock value in September.

The announcement was not unexpected as news trickled through the grapevine last week that a major pharma company is in talks with Acceleron for a potential buyout. On Monday, the Wall Street Journal reported that Merck was the highest bidder, edging out fellow competitors like Bristol Myers Squibb.

The acquisition will let Merck lay its hands on Acceleron's lead cardiovascular candidate, sotatercept, an investigational reverse-remodeling agent proposed to rebalance TGF-beta superfamily signaling in patients with pulmonary arterial hypertension (PAH), a rare, progressive, and life-threatening blood vessel disorder. However, Merck might have to divest its own PAH asset, Adempas, an oral sGC stimulator it gained through a 2014 deal with Bayer, over concerns of market monopoly.

GO Prime with only $1.49 now

LATEST
Beyond Pouch Packaging: Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States
2025-02-13
NASA Says There’s a 1 in 43 Chance an Asteroid 2024 YR4 Could Hit Earth in 2032—Should We Worry?
2025-02-13
Sodium Channel Targeting: What the Latest FDA Non-Opioid Approval Reveals About the Next Big Thing in Pain Relief
2025-02-12
Novartis Reclaims Abelacimab in $925M Deal to Boost Cardiovascular Portfolio
2025-02-12
GLP-1 Weight Loss Drugs Might Cause Blindness
2025-02-11
South Korea’s Olix Strikes $660M Deal with Eli Lilly for Phase 1 MASH candidate
2025-02-11
22 USA States Sue Trump Administration for Slashing Critical Medical Research Funding
2025-02-11
EVENT
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-04
MIXiii Health-Tech.IL
Jerusalem, Israel
2025-03-05
Medical Japan
Osaka, Japan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
Scroll to Top